Cedric Schneider

Title: Cedric Schneider: Innovator in Cancer Research

Introduction

Cedric Schneider is a notable inventor hailing from Val-de-Bride, France. He has made significant contributions to the field of cancer research through his innovative work and patent. His research primarily focuses on the development of compounds that target specific cancer-related proteins, showcasing his dedication to advancing medical science.

Latest Patents

Cedric Schneider holds a patent for "Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl." This invention relates to compounds of a specific formula designed to inhibit key proteins associated with various cancers, providing potential new avenues for treatment options.

Career Highlights

Throughout his career, Schneider has worked with esteemed institutions, including Università degli Studi di Milano-Bicocca and Université de Genève. His experiences in these research institutions have contributed to his expertise and innovation in developing effective cancer therapies.

Collaborations

During his professional journey, Cedric Schneider has collaborated with notable individuals, including Carlo Gambacorti Passerini and Luca Mologni. These collaborations have enriched his research and contributed to significant advancements in the field.

Conclusion

Cedric Schneider's contributions to cancer research through his patent exemplify the impact of innovation in medicine. His work not only showcases his capabilities as an inventor but also highlights the importance of collaboration in the advancement of science.